GlassScriptPhysician profile
Peter A Felice
NPI 1992966881
$9,998.28
in general payments reported to CMS, 2019-2025
15 companies · $1,047 in 2025
The $1,047 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $832 · 2020: $5,166 · 2021: $1,058 · 2022: $636 · 2023: $577 · 2024: $682 · 2025: $1,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839 · Travel and Lodging: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.45 |
| Travel and Lodging | $466.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $5,763.80 | 2019-2022 | |
| Abbvie INC. | $1,339.13 | 2023-2025 | |
| Allergan, INC. | $1,208.68 | 2021-2022 | |
| Motiva USA, LLC | $828.09 | 2024-2025 | |
| Mentor Worldwide LLC | $239.30 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Tepha INC | $207.84 | 2019 | |
| Tela Bio, INC. | $112.51 | 2021-2024 | Ovitex 2s |
| Musculoskeletal Transplant Foundation INC. | $80.89 | 2019-2021 | |
| Acelrx Pharmaceuticals, INC. | $69.08 | 2019-2021 | |
| Merz North America, INC. | $45.09 | 2020 | |
| Baxter Healthcare | $27.00 | 2021 | |
| Davol INC. | $25.32 | 2021 | |
| Medline Industries LP | $21.72 | 2019 | |
| Galderma Laboratories, L.P. | $15.68 | 2024 | |
| Bard Peripheral Vascular, INC. | $14.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Felice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.